Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LyondellBasell's Earnings Lag Estimates, Sales Beat in Q1

In This Article:

LyondellBasell Industries N.V. LYB recorded a first-quarter 2025 profit of $177 million or 54 cents compared with the year-ago quarter's profit of $473 million or $1.44 per share.

LYB posted adjusted earnings of 33 cents, down 74.8% from the year-ago quarter figure of $1.31. It missed the Zacks Consensus Estimate of 36 cents.

The company’s net sales in the first quarter were $7,677 million, which beat the Zacks Consensus Estimate of $7,593.3 million. Net sales decreased around 7.6% from $8,304 million in the prior-year quarter.

(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)

LyondellBasell Industries N.V. Price, Consensus and EPS Surprise

LyondellBasell Industries N.V. price-consensus-eps-surprise-chart | LyondellBasell Industries N.V. Quote

LYB’s Segment Highlights

In the Olefins & Polyolefins — Americas division, revenues decreased roughly 13.6% year over year to $2,481 million in the first quarter. The figure missed the Zacks Consensus Estimate of $2,737.8 million. EBITDA fell by $270 million from the first quarter of 2024. The decline in Olefins results was about $120 million, mainly due to reduced ethylene margins caused by higher energy costs and lower prices for co-products.

The Olefins & Polyolefins — Europe, Asia, the international segment recorded revenues of $2,600 million, down 5.3% from the prior-year quarter. The figure beat the Zacks Consensus Estimate of $2,550.8 million. Olefins results declined by around $20 million year over year, primarily due to reduced margins from increased feedstock costs. This was partially offset by higher ethylene prices, while lower volumes from unplanned downtime adversely impacted results.

The Advanced Polymer Solutions segment posted revenues of $908 million, down 5.9% from $965 million in the prior-year quarter. The figure lagged the Zacks Consensus Estimate of $948.4 million. EBITDA rose by $11 million year over year, mainly due to improved sales margins and better cost efficiency.

Revenues in the Intermediates and Derivatives segment decreased around 11.1% on a year-over-year basis to $2,298 million. The figure missed the Zacks Consensus Estimate of $2,472.9 million. Propylene Oxide & Derivatives results fell by about $25 million from the previous period, primarily due to reduced margins on raw materials and derivatives.

The Technology segment’s revenues were $120 million in the reported quarter, down around 37.5% year over year. The figure lagged the Zacks Consensus Estimate of $175.4 million. EBITDA fell by $66 million from the first quarter of 2024. This decline was due to reduced licensing revenues from fewer contracts, along with lower catalyst margins and volumes driven by weaker market sentiment.